Back to search
FDAFDA · Food and drugs·Recall number Z-0938-2026

HemosIL SynthAFax. Partial Thromboplastin Time Tests.

Published December 24, 2025 · Recall initiated: November 18, 2025

Summary

FDA records medical device Class III recall Z-0938-2026, published December 24, 2025 and initiated November 18, 2025. Recalling firm: Instrumentation Laboratory; Status: Ongoing; Reported quantity: 4,506 units; Lot: Part No. 0020007400; UDI: 08426950087649; Lot No. (Exp. Date) N0542231(2026-06-30), N0250088(2027-04-30, N0452249 (2027-06-30). Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Recalled lots were manufactured with double the amount of preservative concentration.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Instrumentation Laboratory
Distributor
Domestic: CA, CO, FL, NY; Foreign: AR, AT, CA, CZ, DE, DK, ES, FR, GB, IE, IL, IN, IT, JP, LK, NL, PL, PT, RO, RS, TH, VN.
Lot
Part No. 0020007400; UDI: 08426950087649; Lot No. (Exp. Date) N0542231(2026-06-30), N0250088(2027-04-30, N0452249 (2027-06-30).
Risk classification
Class III
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was HemosIL SynthAFax. Partial Thromboplastin Time Tests. recalled?

Yes. FDA published recall Z-0938-2026 on December 24, 2025. Reported hazard: Recalled lots were manufactured with double the amount of preservative concentration.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail